| 2024-02-09 | Sale | Merck & Co., Inc. MRK | Executive VP & President, MRL | 14,702 0.0006% | $125.50 | $1.85M | +2.02% | |
| 2024-01-09 | Sale | Recursion Pharmaceuticals, Inc. RXRX | director | 29,000 0.0136% | $13.66 | $396,214 | -29.31% | |
| 2021-12-07 | Sale | Recursion Pharmaceuticals, Inc. RXRX | director | 31,800 0.0186% | $20.48 | $651,261 | -52.65% | |
| 2021-11-19 | Sale | Recursion Pharmaceuticals, Inc. RXRX | director | 26,948 0.0162% | $20.20 | $544,452 | -48.51% | |
| 2021-11-17 | Sale | Recursion Pharmaceuticals, Inc. RXRX | director | 11,252 0.0069% | $20.04 | $225,472 | -47.35% |